Bristol Myers liver cancer treatment meets main goal of late-stage study

(Reuters) – Bristol Myers Squibb said on Wednesday a combination of its drugs, Opdivo and Yervoy, met the main goal of a late-stage study evaluating it as a first-line treatment for a type of liver cancer.

(Reporting by Puyaan Singh)